Skip to main content

Global Endoscopic Submucosal Dissection Market Sustains ~6% CAGR with Awareness Rise by 2030

 


The endoscopic submucosal dissection (ESD) market is expanding at a steady CAGR of ~6%, driven by the increasing prevalence of gastrointestinal cancers and a growing preference for minimally invasive procedures. Advancements in endoscopic imaging and electrosurgical tools are improving procedural safety and efficacy, while greater awareness of early cancer detection and enhanced healthcare infrastructure further support market growth. However, the technical complexity of ESD, which demands specialized training, along with high procedural costs, poses challenges to broader adoption, particularly in regions with limited access to skilled endoscopists. 

Endoscopic submucosal dissection (ESD) is a specialized, minimally invasive procedure designed for the removal of early-stage tumors in the digestive tract, including the esophagus, stomach, and colon. Unlike conventional endoscopic mucosal resection (EMR), which may require piecemeal excision, ESD allows for en-bloc resection, reducing the likelihood of incomplete removal and recurrence. The procedure utilizes high-precision electrosurgical knives to dissect the submucosal layer, ensuring deeper and more thorough tumor removal while preserving organ functionality. As a result, ESD has emerged as a critical technique in gastrointestinal oncology, particularly in regions with established early cancer screening programs.

Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/endoscopic-submucosal-dissection-market/request-sample/

Increasing gastrointestinal cancer cases as a market catalyst

One of the most significant factors propelling the ESD market is the rising incidence of gastrointestinal malignancies, including esophageal, gastric, and colorectal cancers. With the expansion of cancer screening programs worldwide, early detection rates have improved, necessitating effective treatment approaches that minimize invasiveness while maximizing curative potential. ESD offers a superior alternative to traditional surgical interventions, allowing for precise tumor removal without the need for organ resection. The growing geriatric population, which is at a higher risk for digestive tract cancers, further amplifies demand for advanced endoscopic procedures. Countries such as Japan and South Korea, where early cancer detection programs are well-integrated into healthcare systems, have set benchmarks for ESD adoption. As awareness and expertise grow globally, more healthcare facilities are expected to incorporate ESD into their treatment protocols, driving market expansion.

Hybrid ESD techniques optimizing efficiency and safety

A key advancement accelerating market growth is the development of hybrid ESD techniques, which combine conventional ESD with complementary methods to streamline the procedure and enhance patient outcomes. Innovations such as hybrid knife-assisted ESD, water-jet ESD, and ESD combined with endoscopic mucosal resection (EMR) are simplifying tumor resection while reducing procedural time and associated risks. These techniques allow for more controlled dissection and improved visualization, addressing one of the major limitations of standard ESD—the prolonged duration and steep learning curve. Additionally, the integration of robotic-assisted endoscopy and improved hemostatic technologies is enhancing procedural precision, making ESD more accessible to a broader range of endoscopists. Such advancements are expected to play a pivotal role in expanding ESD’s clinical applications, increasing adoption rates, and driving further market growth.

Competitive Landscape Analysis

The global endoscopic submucosal dissection market is marked by the presence of established and emerging market players such as Olympus Corporation, Boston Scientific Corporation, Hoya Corporation (PENTAX Medical), FUJIFILM Holdings Corporation, Karl Storz GmbH & Co. KG, Micro-Tech Endoscopy, Medtronic Plc, CONMED Corporation, STERIS plc., Cook Group, Creo Medical among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis:
https://meditechinsights.com/endoscopic-submucosal-dissection-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global endoscopic submucosal dissection market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, indication, and end-user.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Gastroscopes and Colonoscopes
    • Injection Agents
    • Knives
    • Tissue Retractors
    • Graspers/ Clips
    • Other
  • Market Size & Forecast (2023-2030), By Indication, USD Million
  •  
    • Esophageal Cancer
    • Stomach Cancer
    • Colon Cancer
  • Market Size & Forecast (2023-2030), By End-user, USD Million
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more